近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Wang X, Liu M, Zhu MJ, Shi L, Liu L, Zhao YL, Cheng L, Gu YJ, Zhou MY, Chen L, Kumar A, Wang Y*. Resveratrol Protects the Integrity of Alveolar Epithelial Barrier via SIRT1/PTEN/p-Akt Pathway in Methamphetamine-Induced Chronic Lung Injury. Cell Prolif. 2020 Mar;53(3):e12773. doi: 10.1111/cpr.12773. Epub 2020 Feb 5.
2. Liang LY, Wang MM, Liu M, Zhao W, Wang X, Shi L, Zhu MJ, Zhao YL, Liu L, Maurya P,Wang Y*. Chronic toxicity of methamphetamine:Oxidative remodeling of pulmonary arteries. Toxicol In Vitro. 2019 Oct 16:104668. doi: 10.1016/j.tiv.2019.104668.
3. Wang Y, Hao Q, Florence JM, Jung BG, Kurdowska AK, Samten B, Idell S, Tang H*. Influenza Virus Infection Induces ZBP1 Expression and Necroptosis in Mouse Lungs. Front Cell Infect Microbiol. 2019 Aug 7;9:286. doi: 10.3389/fcimb.2019.00286. eCollection 2019.
4. Wang Y*, Gu YH, Liang LY, Liu M, Jiang B, Zhu MJ, Wang X, Shi L. Concurrence of autophagy with apoptosis in alveolar epithelial cells contributes to chronicpulmonary toxicity induced by methamphetamine. Cell Prolif. 2018 Jun 28:e12476. doi: 10.1111/cpr.12476. [Epub ahead of print]
5. Wang Y*, Gu YH, Liu M, Bai Y, Liang LY, Wang HL. TBHQ Alleviated Endoplasmic Reticulum Stress-Apoptosis and Oxidative Stress by PERK-Nrf2 Crosstalk in Methamphetamine-Induced Chronic Pulmonary Toxicity. Oxid Med Cell Longev. 2017;2017:4310475.
6. Wang Y*, Gu YH, Liu M, Bai Y, Wang HL. Fluoxetine protects against methamphetamine induced lung inflammation by suppressing oxidative stress through the SERT/p38 MAPK/Nrf2 pathway in rats. Mol Med Rep. 2017 Feb; 15(2): 673-680.
7. Gu YH,Wang Y*, Bai Y, Liu M, Wang HL.Endoplasmic reticulum stress and apoptosis via PERK-eIF2α-CHOP signaling in the methamphetamine-induced chronic pulmonary injury. Environ Toxicol Pharmacol. 2017 Jan;49:194-201.
8. YANG BAI,YUN WANG*, MING LIU, YU HAN GU, BIN JIANG, XU WU, HUAI LIANG WANG.Suppression of nuclear factor erythroid 2 related factor 2 mediated antioxidative defense in the lung injury induced by chronic exposure to methamphetamine in rats. Mol Med Rep. 15: 3135-3142, 2017.
9. YANG BAI, ZHONG-XIA LI, HUAI-LIANG WANG, GUO-CHAO LIAN andYUN WANG*. The protective effects of PCPA against monocrotaline-inducedpulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB. Int J Mol Med. 40: 155-163, 2017
10. Wang Yun, Liu Ming, Wang Han-Ming, Bai Yang, Zhang Xin-Hua, Sun Ying-Xian, *Wang Huai-Liang,Involvement of serotonin mechanism in methamphetamine-induced chronic pulmonary toxicity in rats, Human & Experimental Toxicology， 32(7)，pp 736-746，2013.
11. Wang, Yun, Han, Dan-Dan, Wang, Han-Ming, Liu, Ming, Zhang, Xin-Hua, *Wang, Huai-Liang,Downregulation of osteopontin is associated with fluoxetine amelioration of monocrotaline-induced pulmonary inflammation and vascular remodelling, Clinical and Experimental Pharmacology and Physiology, 38(6), pp 365-372, 2011.
12. Wang, Yun, Zhang, Xin-Hua, *Wang, Huai-Liang,Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats, Canadian Journal of Physiology and Pharmacology, 89(5), pp 345-354, 2011.
13. Liu Ming,Wang Yun, Wang Han-Ming, Bai Yang, Zhang Xin-Hua, Sun Ying-Xian, *Wang Huai-Liang,Fluoxetine Attenuates Chronic Methamphetamine-induced Pulmonary Arterial Remodeling: Possible Involvement of Serotonin Transporter and Serotonin 1B Receptor, Basic and Clinical Pharmacology and Toxicology, 112(3), pp 77-82, 2013.
14. Han, Dan-Dan,Wang, Yun, Zhang, Xin-Hua, Liu, Jin-Rong, *Wang, Huai-Liang,Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor, Canadian Journal of Physiology and Pharmacology, 90(4), pp 445-454, 2012.
15. Wang, Han-Ming,Wang, Yun, Liu, Ming, Bai, Yang, Zhang, Xin-Hua, Sun, Ying-Xian, *Wang, Huai-Liang, 2012,Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats, Canadian Journal of Physiology and Pharmacology, 90(11), pp 1506-1515, 2012.
16. Bai Y, Wang HM, Liu M, Wang Y, Lian GC, Zhang XH, Kang J, Wang HL*.4-Chloro-DL-phenylalanine protects against monocrotaline induced pulmonary vascular remodeling and lung inflammation. Int J Mol Med. 2014 Feb;33(2):373-82.
17. Li XQ, Hong Y, Wang Y, Zhang XH, Wang HL*. Sertraline protects against monocrotaline-induced pulmonary hypertension in rats.Clin Exp Pharmacol Physiol. 2006 Nov; 33(11):1047-51.
18. Xue-Qin LI, Xin-Hua ZHANG, Fan-Rui MENG,Yun WANG, Xu CAO, Huai-Liang WANG*. SSRIs Protect Against Monocrotaline-Induced Pulmonary Hypertension in Rats. Acta Pharmacologica Sinica 2006; Supplement 1:380.
19. Song ZH, Wang HM, Liu M, Bai Y, Wang Y, Wang HL*. Involvement of S100A4/Mts1 and associated proteins in the protective effect of fluoxetineagainst MCT - Induced pulmonary hypertension in rats.J Chin Med Assoc. 2018 Jul 18. pii: S1726-4901(18)30162-X. doi: 10.1016/j.jcma.2018.03.013. [Epub ahead of print]
教材编写：
1. 副主编，《临床药理学》（“十三五”），高等教育出版社，2020.
2. 编委，《药理学》（“十三五”），人民卫生出版社，2019.
3. 副主编，《临床药物治疗学》（“十三五”），吉林科技出版社，2018.
4. 编委，《临床药物治疗学》，上海科学技术出版社，2017.
5. 编委，《药事管理学》（“十三五”），中国医药科技出版社，2016.
6. 编委，《临床药理学》（“十一五”），高等教育出版社，2015.
7. 编委，《临床药物治疗学》，上海科学技术出版社，2011.
京公网安备 11010802027423号